{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:50:06Z","timestamp":1790895006802,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.antiviral.2011.05.006","type":"journal-article","created":{"date-parts":[[2011,5,22]],"date-time":"2011-05-22T08:45:25Z","timestamp":1306053925000},"page":"89-93","source":"Crossref","is-referenced-by-count":58,"title":["Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus"],"prefix":"10.1016","volume":"91","author":[{"given":"Stephan","family":"\u00d6lschl\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.05.006_b0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7164\/antibiotics.21.649","article-title":"Antiviral activity of mycophenolic acid. Studies on antiviral and antitumor antibiotics. IV","volume":"21","author":"Ando","year":"1968","journal-title":"J. Antibiot. (Tokyo)."},{"key":"10.1016\/j.antiviral.2011.05.006_b0010","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/JVI.78.6.3162-3169.2004","article-title":"Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus","volume":"78","author":"Asper","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.05.006_b0015","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1016\/S0021-9258(19)74507-4","article-title":"Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis","volume":"268","author":"Balzarini","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2011.05.006_b0020","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2011.05.006_b0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.35.4.679","article-title":"Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide and related compounds","volume":"35","author":"De Clercq","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.05.006_b0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.11.6.946","article-title":"Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate","volume":"11","author":"Eriksson","year":"1977","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.05.006_b0035","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1128\/AAC.33.10.1668","article-title":"Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction","volume":"33","author":"Fernandez-Larsson","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.05.006_b0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1042\/bj1130515","article-title":"The inhibition of nucleic acid synthesis by mycophenolic acid","volume":"113","author":"Franklin","year":"1969","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2011.05.006_b0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0006-291X(79)91853-9","article-title":"The broad spectrum antiviral agent ribavirin inhibits capping of mRNA","volume":"89","author":"Goswami","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2011.05.006_b0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.antiviral.2004.05.001","article-title":"Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro","volume":"63","author":"G\u00fcnther","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.05.006_b0055","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.01657-09","article-title":"An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome","volume":"84","author":"Lelke","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.05.006_b0060","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.05.006_b0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1124\/mol.105.020057","article-title":"The anti-yellow fever virus activity of ribavirin is independent of error-prone replication","volume":"69","author":"Leyssen","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2011.05.006_b0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2011.05.006_b0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.05.006_b0080","doi-asserted-by":"crossref","first-page":"e1001038","DOI":"10.1371\/journal.ppat.1001038","article-title":"The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription","volume":"6","author":"Morin","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.antiviral.2011.05.006_b0085","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/JCM.02351-09","article-title":"Improved detection of Lassa virus by reverse transcription-PCR targeting the 5\u2032 region of S RNA","volume":"48","author":"\u00d6lschl\u00e4ger","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2011.05.006_b0090","doi-asserted-by":"crossref","unstructured":"Panning, M., Laue, T., \u00d6lschl\u00e4ger, S., Eickmann, M., Becker, S., Raith, S., Courbot, M.C., Nilsson, M., Gopal, R., Lundkvist, A., Caro, A., Brown, D., Meyer, H., Lloyd, G., K\u00fcmmerer, B.M., G\u00fcnther, S., Drosten, C., 2007. Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J. Infect. Dis. 196(Suppl. 2), S199\u2013S204.","DOI":"10.1086\/520600"},{"key":"10.1016\/j.antiviral.2011.05.006_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0042-6822(02)00046-6","article-title":"Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV)","volume":"308","author":"Ruiz-Jarabo","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2011.05.006_b0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/JVI.77.1.481-488.2003","article-title":"Ribavirin causes error catastrophe during Hantaan virus replication","volume":"77","author":"Severson","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.05.006_b0105","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.05.006_b0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/095632020101200602","article-title":"Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro","volume":"12","author":"Smee","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2011.05.006_b0115","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1073\/pnas.70.4.1174","article-title":"Mechanism of action of 1-beta-D-ribofuranosyl-1, 2, 4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent","volume":"70","author":"Streeter","year":"1973","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.antiviral.2011.05.006_b0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.00790-06","article-title":"Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5\u2032-triphosphate, not with inhibition of IMP dehydrogenase","volume":"51","author":"Sun","year":"2007","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211003020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211003020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T22:41:03Z","timestamp":1637707263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211003020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0166354211003020"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.05.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}